USB1是一种调节血液形成的miRNA死亡酶
Ho-Chang Jeong1,2, Siddharth Shukla3,4, Wilson Chun Fok1,2
1Division of Hematology, Department of Medicine, Washington University in St. Louis, St. Louis, MO 63110, USA.
概括
RNA外核酶USB1的突变导致中性质皮肤病 (PN) 的血液衰竭. 通过恢复微RNA水平,抑制PAPD5/7挽救了血液形成,这表明了新的PN疗法.
科学领域:
- 分子生物学
- 血液学
- 遗传学
背景情况:
- 在3'至5'RNA外核酶USB1中发生的突变与带有中性质衰竭 (PN) 的皮质病有关,这种病症会导致造血失败.
- 尽管已知USB1在U6小核RNA成熟中的作用,但PN的精确分子机制仍然不清楚,因为mRNA前拼接不受影响.
研究的目的:
- 研究USB1突变在人类造血中的作用.
- 阐明导致PN的造血失败的分子途径.
- 为了确定PN的潜在治疗点.
主要方法:
- 在USB1中产生具有PN相关突变 (c.531_delA) 的人类胚胎干细胞.
- 在USB1突变细胞中分析了microRNA (miRNA) 水平和3'-end腺化.
- 评估了抑制PAPD5/7对USB1突变体的血液形成的影响.
主要成果:
- 在USB1中c.531_delA突变会损害人类的造血.
- 由于无法移除由PAPD5 / 7添加的3'-end腺化尾巴,导致失调的miRNA水平,导致USB1突变的造血失败.
- 在USB1突变体中抑制PAPD5/7挽救了血液形成.
结论:
- USB1作为一个关键的miRNA死亡酶.
- 这项研究确定了PAPD5/7作为USB1相关的造血失败的关键因素.
- 抑制PAPD5/7是一种潜在的治疗策略.
更多相关视频
11:06Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
Published on: September 20, 2017
6.2K
11:00Biotin-based Pulldown Assay to Validate mRNA Targets of Cellular miRNAs
Published on: June 12, 2018
13.9K
相关概念视频
MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Role of Hematopoietic Growth Factors
1.5K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.5K
Hematopoiesis
5.5K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.5K
Nonsense-mediated mRNA Decay
10.7K
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
10.7K
Multipotency of Hematopoietic Stem Cells
3.2K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.2K
